These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5748382)

  • 1. Ethebenecid (Urelim).
    Drug Ther Bull; 1968 Dec; 6(26):102-3. PubMed ID: 5748382
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of 100 gout patients treated with benzodiarone].
    Mugler A
    Rev Rhum Mal Osteoartic; 1967 Apr; 34(4):199-208. PubMed ID: 6059925
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of benziodarone on the renal excretion of uric acid].
    Podevin R; Paillard F; Amiel C; Richet G
    Rev Fr Etud Clin Biol; 1967 Apr; 12(4):361-7. PubMed ID: 6051917
    [No Abstract]   [Full Text] [Related]  

  • 4. An evidence based appraisal of the management of nontophaceous interval gout.
    Ferraz MB
    J Rheumatol; 1995 Sep; 22(9):1618-9. PubMed ID: 8523332
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of gout in the senile age].
    Silvi G; Pardini C
    Policlinico Med; 1971; 78(5):222-8. PubMed ID: 5131996
    [No Abstract]   [Full Text] [Related]  

  • 6. Gout: joint pain and more.
    Harv Mens Health Watch; 2007 Dec; 12(5):1-3. PubMed ID: 18225332
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of primary gout: the present status.
    Gutman AB
    Arthritis Rheum; 1965 Oct; 8(5):911-20. PubMed ID: 5863107
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 9. Allopurinol in the treatment of gout.
    Rundles RW; Metz EN; Silberman HR
    Ann Intern Med; 1966 Feb; 64(2):229-58. PubMed ID: 5322938
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
    Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
    Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of gouty tophi by protracted use of uricosuric agents.
    YU TF; GUTMAN AB
    Am J Med; 1951 Dec; 11(6):765-9. PubMed ID: 14902847
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment and prevention of gout with uricosuric agents].
    May P; Lux B
    Med Monatsschr Pharm; 1978 May; 1(5):147-50. PubMed ID: 756510
    [No Abstract]   [Full Text] [Related]  

  • 14. The history and future of probenecid.
    Robbins N; Koch SE; Tranter M; Rubinstein J
    Cardiovasc Toxicol; 2012 Mar; 12(1):1-9. PubMed ID: 21938493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uricosuric and anti-gout action of certain benzofuran derivatives].
    Delbarre F; Auscher C; Amor B
    Presse Med (1893); 1965 Nov; 73(48):2725-6. PubMed ID: 5842108
    [No Abstract]   [Full Text] [Related]  

  • 16. Tophus in the odontoid process of C2.
    Niva M; Tallroth K; Konttinen YT
    Clin Exp Rheumatol; 2006; 24(1):112. PubMed ID: 16539832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gout: will it be eliminated?].
    Coste F
    Bull Acad Natl Med; 1967 May; 151(17):314-25. PubMed ID: 4875741
    [No Abstract]   [Full Text] [Related]  

  • 18. [Allopurinol in therapy of gout].
    Policlinico Prat; 1965 Sep; 72(36):1218-21. PubMed ID: 5854426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gout and benziodarone].
    Thomas J
    Rein Foie; 1967; 10():249-60. PubMed ID: 6081452
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of gout.
    Mason RM
    Rep Rheum Dis; 1968 Jun; 32():1-2. PubMed ID: 5656162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.